Association of MPPED2 gene variant rs10767873 with kidney function and risk of cardiovascular disease in patients

Yixuan Zhong1, Yiyi Wu1,2, Yunyun Yang3

  • 1National Clinical Research Center of Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, 100037, China.

Journal of Human Genetics
|February 16, 2023
PubMed

Insights

Genetic variants in the MPPED2 gene influence kidney function in hypertensive patients. The rs10767873 variant is linked to higher estimated glomerular filtration rate and increased cardiovascular disease risk.

Area of Science:

  • Genetics
  • Nephrology
  • Cardiology

Background:

  • Kidney function changes and chronic kidney disease (CKD) progression are linked to cardiovascular disease (CVD) risk.
  • Genetic factors influence these associations, but their role in hypertensive patients on medication is unclear.

Purpose of the Study:

  • To investigate the association between genetic variants and kidney function (eGFR) in Chinese hypertensive patients.
  • To explore the relationship between these variants and the risk of CVD events.

Main Methods:

  • Analyzed 30 variants in 22 genes in 1911 hypertensive patients (1220 with CKD).
  • Used multivariate linear regression, adjusting for risk factors and antihypertensive drug use.
  • Followed patients for a median of 2.25 years to document CVD events.

Main Results:

  • The MPPED2 gene variant rs10767873T allele was associated with higher eGFR, lower serum creatinine, and lower serum uric acid.
  • This variant did not correlate with CKD risk, irrespective of antihypertensive drug type.
  • Patients with the rs10767873TT genotype showed a significantly increased risk of CVD events (HR=1.74).

Conclusions:

  • The MPPED2 gene variant rs10767873 is associated with kidney function in Chinese hypertensive individuals.
  • This genetic variant is also linked to an elevated risk of cardiovascular disease events in this population.

Related Concept Videos

Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
2.2K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
13.8K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
29
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
52
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
56
Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
14